Isracann Biosciences Inc.
ISCNF · OTC
5/31/2022 | 5/31/2021 | 5/31/2020 | 5/31/2019 | |
|---|---|---|---|---|
| Market Cap | $9,399 | $33,086 | $41,536 | $5,178 |
| - Cash | $214 | $1,958 | $3,891 | $4,178 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $9,185 | $31,128 | $37,645 | $1,001 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$42 | -$41 | -$45 | -$45 |
| % Margin | – | – | – | – |
| EBITDA | -$2,392 | -$4,778 | -$11,177 | -$5,275 |
| % Margin | – | – | – | – |
| Net Income | -$4,693 | -$25,155 | -$24,202 | -$9,598 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.032 | -0.18 | -0.26 | -0.75 |
| % Growth | 82.3% | 30.8% | 65.3% | – |
| Operating Cash Flow | -$1,755 | -$4,230 | -$10,400 | -$2,943 |
| Capital Expenditures | $0 | -$14 | -$509 | -$204 |
| Free Cash Flow | -$1,755 | -$4,243 | -$10,909 | -$3,147 |